These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 7799243)

  • 1. Anxiety or depression during withdrawal of hypnotic treatments.
    Lader M
    J Psychosom Res; 1994; 38 Suppl 1():113-23; discussion 118-23. PubMed ID: 7799243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rebound insomnia and newer hypnotics.
    Lader M
    Psychopharmacology (Berl); 1992; 108(3):248-55. PubMed ID: 1523276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypnotic discontinuation in chronic insomnia: impact of psychological distress, readiness to change, and self-efficacy.
    Belleville G; Morin CM
    Health Psychol; 2008 Mar; 27(2):239-48. PubMed ID: 18377143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypnotic Discontinuation in Chronic Insomnia.
    Hintze JP; Edinger JD
    Sleep Med Clin; 2020 Jun; 15(2):147-154. PubMed ID: 32386690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypnotic Discontinuation in Chronic Insomnia.
    Hintze JP; Edinger JD
    Sleep Med Clin; 2018 Jun; 13(2):263-270. PubMed ID: 29759276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypnotic drugs for 1984.
    Oswald I
    Psychopharmacology Suppl; 1984; 1():84-90. PubMed ID: 6147844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological treatment of insomnia.
    Maczaj M
    Drugs; 1993 Jan; 45(1):44-55. PubMed ID: 7680984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational use of anxiolytic/sedative drugs.
    Lader M; Petursson H
    Drugs; 1983 May; 25(5):514-28. PubMed ID: 6134609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Main neuroendocrine features and therapy in primary sleep troubles.
    Amihăesei IC; Mungiu OC
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):862-6. PubMed ID: 23272543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of short- and long-acting hypnotics in clinical medicine.
    Nicholson AN
    Br J Clin Pharmacol; 1981; 11 Suppl 1(Suppl 1):61S-69S. PubMed ID: 6133538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Benzodiazepines and sleep].
    Ansseau M
    Acta Psychiatr Belg; 1985; 85(4):522-32. PubMed ID: 2865871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relaxation to assist sleep medication withdrawal.
    Lichstein KL; Peterson BA; Riedel BW; Means MK; Epperson MT; Aguillard RN
    Behav Modif; 1999 Jul; 23(3):379-402. PubMed ID: 10467890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rebound insomnia and rebound anxiety: a review.
    Kales A; Soldatos CR; Bixler EO; Kales JD
    Pharmacology; 1983; 26(3):121-37. PubMed ID: 6132413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review: Adjunctive pharmacologic approaches for benzodiazepine tapers.
    Welsh JW; Tretyak V; McHugh RK; Weiss RD; Bogunovic O
    Drug Alcohol Depend; 2018 Aug; 189():96-107. PubMed ID: 29906718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life in older adults receiving medications for anxiety, depression, or insomnia: findings from a community-based study.
    Stein MB; Barrett-Connor E
    Am J Geriatr Psychiatry; 2002; 10(5):568-74. PubMed ID: 12213691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rebound insomnia and hypnotic self administration.
    Roehrs T; Merlotti L; Zorick F; Roth T
    Psychopharmacology (Berl); 1992; 107(4):480-4. PubMed ID: 1603890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recommendations for the diagnosis and therapy of insomnia. German Society of Sleep Research and Sleep Medicine DGSM].
    Clarenbach P; Steinberg R; Weess HG; Berger M
    Nervenarzt; 1995 Oct; 66(10):723-9. PubMed ID: 7501087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sleep studies and rebound insomnia: methodological problems, laboratory findings, and clinical implications.
    Lader M; Lawson C
    Clin Neuropharmacol; 1987 Aug; 10(4):291-312. PubMed ID: 2902919
    [No Abstract]   [Full Text] [Related]  

  • 19. Rebound insomnia: its determinants and significance.
    Roehrs T; Vogel G; Roth T
    Am J Med; 1990 Mar; 88(3A):39S-42S. PubMed ID: 1968719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Which antipsychotic drugs are proper for HIV patients?].
    Holm S; Perro C
    MMW Fortschr Med; 2010 Apr; 152(17):36-8. PubMed ID: 20509258
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.